Mamoura Diversified Global Holding PJSC's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed Jan 26, 2023
- Accession no.
- 0001839882-23-001552
- Filed
- Jan 26, 2023, 4:11 PM ET
- Trade date
- Jan 25, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $193.3K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mamoura Diversified Global Holding PJSCCIK 0001419351 | 10% Owner |
| Mubadala Investment Co PJSCCIK 0001704268 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 25, 2023 | Class A Common Stock | PPurchaseAcquired | +24,526 | $7.88F1 | +$193,267.33 | 12,346,258 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were purchase in multiple transactions at prices ranging from $7.75 to $7.97, inclusive. The reporting person undertakes to provide to Recursion Pharmaceuticals, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
Referenced by the price of 1 transaction in Table I.
Remarks
6. The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Exchange Act.